26 March 2015 -- A new report on the affordability of new medicines in Europe shows that cooperation and transparency are the best tools to ensure equitable pricing and access. As the number of new medicines introduced in Europe rises, governments need novel policy approaches to evaluate the cost–effectiveness of new drugs and make informed public health choices.
Ebola specific prevention and treatment tools do not exist at the moment. In response to the severity and breadth of the current epidemic in West Africa, WHO has been spearheading efforts to galvanize the research and development of vaccines, treatments and diagnostics to curb the outbreak and ensure that these tools, if safe and effective, are also available for potential future outbreaks. To that end, WHO has convened the affected countries, donor and scientific communities, civil society and industry to gather the best evidence available and garner support for accelerated development and testing of the most promising tools. Two vaccines now being tested for safety could go into late phase trials in early 2015 and if results are positive they could be available to the affected populations by mid-next year.
New medicines on the market have given new hope to the millions of people who suffer from Hepatitis C Virus (HCV), a chronic disease that often leads to severe liver disease and kills between 350 000-500 000 people annually.
WHO works closely with Member State governments to assess and promote policy options for increasing access to these medicines, which remain unaffordable to many of those who need them and put an enormous financial strain even on the health systems of high-income countries.
17 April 2015
Pharmacovigilance, or drug safety, is the primary method used to identify hazards associated with medicinal products and with minimizing the risk of any harm that may come to patients.
13 April 2015
The World Health Organization (WHO) has been informed of a potential quality failure of needles produced by the company Terumo Europe, based in Leuven, Belgium...
10 April 2015
Call for public comments on the new financing model for WHO Prequalification and supporting regulatory functions
New funding model, use of the funds raised and timelines for implementation...